Fintel reports that on July 31, 2025, Morgan Stanley upgraded their outlook for Ionis Pharmaceuticals (NasdaqGS:IONS) from ...

Researchers at the National Graphene Institute have developed a new type of antimicrobial coating that could improve hygiene ...

Researchers from New Jersey Institute of Technology (NJIT) have used artificial intelligence to tackle a critical problem ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the Stocks With Huge Catalysts on the Horizon. On July 25, Ionis ...

Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of +218.52% and +66.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock ...

AI is helping scientists crack the code on next-gen batteries that could replace lithium-ion tech. By discovering novel ...

While the top- and bottom-line numbers for Ionis Pharmaceuticals (IONS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key ...

Ionis Pharmaceuticals (NASDAQ:IONS) reported Q2 2025 GAAP revenue and non-GAAP earnings per share that exceeded analyst expectations by wide margins. The profit surge in Q2 2025 included a ...

Researchers developed a 3D printing-based method to tailor metal alloys by composition and structure, creating stronger, ...

A water softener reduces the dissolved calcium, magnesium, and to some degree manganese and ferrous iron ion concentration in ...

Detailed price information for Ionis Pharmaceuticals (IONS-Q) from The Globe and Mail including charting and trades.

The nanomaterial is based on graphene oxide, a single-atom-thick carbon material already known for its moisture-adsorbing ...